Market revenue in 2023 | USD 642.8 million |
Market revenue in 2030 | USD 983.3 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Closure devices |
Fastest growing segment | Heart Valves |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Closure Devices, Heart Valves, Balloons, Catheters, Stents |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Edwards Lifesciences Corp, St. Jude Medical, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pediatric interventional cardiology market will help companies and investors design strategic landscapes.
Closure devices was the largest segment with a revenue share of 34.33% in 2023. Horizon Databook has segmented the U.S. pediatric interventional cardiology market based on closure devices, heart valves, balloons, catheters, stents covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pediatric interventional cardiology market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pediatric interventional cardiology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account